Brief: Vita Life Sciences Sees First Sales Of Around $21.5M-$22.0M
July 23 (Reuters) - Vita Life Sciences Ltd VLS.AX :
* SEES FIRST HALF FY 2020 SALES OF AROUND $21.5M-$22.0M,
WHICH IS
HIGHER THAN PCP
* SEES FIRST HALF FY 2020 EBIT OF AROUND $3.7M-$4.1M, WHICH
IS
HIGHER PCP
* DUE TO ONGOING COMPLEXITIES REGARDING COVID-19, NOT IN A
POSITION TO PROVIDE GUIDANCE FOR FY
Source text for Eikon: ID:nASXFyKCV
Further company coverage: VLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vita Life Sciences
See all newsBrief: Vita Life Sciences Guides H1 Sales At A$46.3 Million-A$47.3 Million
Brief: Vita Life Sciences Sees Pre-Tax Profit A$6.2M-A$6.7M For Half Year
Australia's Vita Life Sciences slips on subdued earnings forecast
Brief: Vita Life Sciences Sees Half Year Sales Of A$39.0M-A$40.0M
Brief: Vita Life Sciences Delays Date To Hold AGM To 22 May